Moclavin (Amoxicillin, Potassium Clavulanate)

Moclavin, a beta‑lactam antibacterial, is employed to manage infections caused by susceptible bacteria across several organ systems.

• Acute otitis media: eradicates the causative pathogens and relieves ear pain.
• Community‑acquired pneumonia: clears pulmonary infection and improves respiratory function.
• Acute bacterial sinusitis: reduces sinus inflammation and restores normal drainage.
• Skin and soft‑tissue infections: eliminates skin‑resident bacteria and promotes wound healing.
• Urinary tract infection: clears urinary pathogens and resolves dysuria.

• Amoxicillin binds to penicillin‑binding proteins, inhibiting the final stages of bacterial cell‑wall peptidoglycan synthesis, which leads to cell lysis. Potassium clavulanate acts as a suicide inhibitor of beta‑lactamase enzymes, protecting amoxicillin from enzymatic degradation and extending its antimicrobial spectrum against beta‑lactamase‑producing organisms.

Adverse reactions may occur with any antibiotic therapy and should be monitored.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools, often self‑limiting.
• Vomiting: occasional emesis.
• Abdominal pain: cramping or discomfort.
• Rash: non‑specific skin eruption.
• Headache: transient mild pain.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with airway compromise.
• Clostridioides difficile‑associated colitis: severe diarrhea with possible colitis.
• Hepatic enzyme elevation: transient increase in liver transaminases.
• Stevens‑Johnson syndrome: severe mucocutaneous blistering.
• Neutropenia: marked reduction in white blood cells.
• Seizures: rare neurotoxic events, especially in renal impairment.

Use of Moclavin requires careful assessment of patient history and clinical status.

• Allergy assessment: avoid in individuals with known penicillin hypersensitivity.
• Renal function: dose adjustment may be needed in severe renal impairment.
• Hepatic disease: monitor liver function tests during therapy.
• Concomitant antibiotics: avoid simultaneous use with bacteriostatic agents unless clinically justified.
• Pregnancy and lactation: prescribe only when benefit outweighs potential risk.
• Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Moclavin may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Allopurinol: increased risk of severe skin reactions.
• Methotrexate: heightened toxicity due to reduced clearance.
• Warfarin: possible enhancement of anticoagulant effect.

Moderate Interactions (Monitor Closely)

• Antacids containing aluminum or magnesium: may reduce oral absorption.
• Oral contraceptives: potential reduction in hormonal efficacy.